The current invention relates to intravenous (IV) infusion devices, including IV catheters. In particular, the invention relates to an IV catheter assembly having a blood control valve therein and an activator attachment that enables access to the interior of the IV catheter assembly.
IV catheters are commonly used for a variety of infusion therapies, including infusing fluids into a patient, withdrawing blood from a patient, or monitoring various parameters of the patient's vascular system. Catheters are typically connected to a catheter adapter that accommodates the attachment of IV tubing to the catheter. Blood control catheters include an internal blood control valve that is opened by the insertion of a male luer or other object into a proximal end of the catheter adapter. Non-limiting examples of blood control valves are disclosed in the United States Patent Application Publication No. 2011/0046570, filed Aug. 20, 2009, titled “Systems and Methods for Providing a Flushable Catheter Assembly,” which is herein incorporated by reference in its entirety. Thus, following placement of the catheter into the vasculature of a patient, an IV fluid source can be connected to the catheter adapter, opening the blood control valve. Thus connected, fluid from the IV source can begin flow into a patient through the catheter.
Some catheter adapters permit verification of proper placement of the catheter in the blood vessel before fluid infusion begins, by providing a flashback chamber of the catheter assembly where a “flashback” of blood can be observed. To confirm flashback in catheter assemblies that do not include a blood control valve, a clinician must manually occlude the vein to prevent undesirable exposure to blood. In contrast, blood control valves can eliminate the need for such manual occlusion, while also reducing the likelihood of blood exposure during catheter placement.
Despite the many advantages of blood control catheters, some traditional procedures involving vascular access systems are not possible with blood control catheters. Devices and systems that overcome these deficiencies are disclosed herein.
The present invention has been developed in response to problems and needs in the art that have not yet been fully resolved by currently available systems and methods. Thus, these systems and methods are developed to provide a valve within a catheter adapter that provides the dual function of a one-way valve through the lumen of the catheter adapter and a port valve.
In one aspect of the invention, a catheter assembly includes a catheter adapter, a port disposed on the catheter adapter, and a valve disposed within the catheter adapter. The catheter adapter has a proximal end, a distal end, and a lumen extending between the proximal end and the distal end. The port opens into the lumen. The valve is disposed within the lumen, and includes a flexible tube portion and a one-way valve portion. A portion of the flexible tube portion covers an opening between the port and the lumen. The one-way valve portion limits fluid flow through the valve to flow in a proximal direction.
These and other features and advantages of the present invention may be incorporated into certain embodiments of the invention and will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter. The present invention does not require that all the advantageous features and all the advantages described herein be incorporated into every embodiment of the invention.
In order that the manner in which the above-recited and other features and advantages of the invention are obtained will be readily understood, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. These drawings depict only typical embodiments of the invention and are not therefore to be considered to limit the scope of the invention.
The presently preferred embodiments of the present invention can be understood by reference to the drawings, wherein like reference numbers indicate identical or functionally similar elements. It will be readily understood that the components of the present invention, as generally described and illustrated in the figures herein, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description, as represented in the figures, is not intended to limit the scope of the invention as claimed, but is merely representative of presently preferred embodiments of the invention.
Moreover, the Figures may show simplified or partial views, and the dimensions of elements in the Figures may be exaggerated or otherwise not in proportion for clarity. In addition, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to a terminal includes reference to one or more terminals. In addition, where reference is made to a list of elements (e.g., elements a, b, c), such reference is intended to include any one of the listed elements by itself, any combination of less than all of the listed elements, and/or a combination of all of the listed elements.
The term “substantially” means that the recited characteristic, parameter, or value need not be achieved exactly, but that deviations or variations, including for example, tolerances, measurement error, measurement accuracy limitations and other factors known to those of skill in the art, may occur in amounts that do not preclude the effect the characteristic was intended to provide.
As used herein, the term “proximal”, “top”, “up” or “upwardly” refers to a location on the device that is closest to the clinician using the device and farthest from the patient in connection with whom the device is used when the device is used in its normal operation. Conversely, the term “distal”, “bottom”, “down” or “downwardly” refers to a location on the device that is farthest from the clinician using the device and closest to the patient in connection with whom the device is used when the device is used in its normal operation.
As used herein, the term “in” or “inwardly” refers to a location with respect to the device that, during normal use, is toward the inside of the device. Conversely, as used herein, the term “out” or “outwardly” refers to a location with respect to the device that, during normal use, is toward the outside of the device.
Referring now to
One of skill in the art will appreciate that the features of the present invention may be incorporated for use with an over-the-needle catheter assembly, which can include the tapered end instead of a beveled cutting surface 48. For example, one of skill in the art will appreciate that a flexible or semi-flexible polymer catheter may be used in combination with a rigid needle to enable insertion of the catheter into a patient. One of skill in the art will further appreciate that surgically implanted catheters or other catheter types may also be used.
Once inserted into a patient, the catheter 12 and catheter adapter 14 provide a fluid conduit to facilitate delivery of a fluid to and/or retrieval of a fluid from a patient, as required by a desired infusion procedure. Thus, in some embodiments the material of the catheter 12 and the catheter adapter 14 are selected to be compatible with bio-fluids and medicaments commonly used in infusion procedures. Additionally, in some embodiments a portion of the catheter 12 and/or catheter adapter 14 is configured for use in conjunction with a section of intravenous tubing 40 to facilitate delivery of a fluid to or removal of a fluid from a patient.
In some embodiments, a proximal end 22 of the catheter adapter 14 includes a flange 28. The flange 28 provides a positive surface that may be configured to enable coupling of intravenous tubing or a conduit coupler 42 to the catheter assembly 10. In some embodiments, the flange 28 includes a set of threads 30. The threads 30 are generally provided and configured to compatibly receive a complementary set of threads 44 comprising a portion of a male luer or conduit coupler 42. The conduit coupler 42 is generally coupled to an end portion of the patient conduit in a fluid-tight manner. In some embodiments, an inner portion of the conduit coupler 42 is extended outwardly to provide a probe surface 46.
In some embodiments, the proximal end 22 to the catheter adapter 14 includes a female luer connector having a female luer taper and/or female luer lock threads. The female luer taper can be disposed at least in part within the proximal portion of the lumen 16 of the catheter adapter 14. Additionally, the flange 28 and/or threads 30 previously mentioned can comprise the female luer lock threads. The female luer connector can thus be configured to connect to a male luer lock or a male luer slip. Each of these components can be sized and configured in conformity with at least some of the International Standards Organization (ISO) standards for female and male luer connections under current or future standards. Accordingly, the proximal end 22 to the catheter adapter 14 can thus be configured to connect to a male luer lock or a male luer slip of the conduit coupler 42, IV line, luer access connector, needle hub, vent plug, or other known or future developed IV device.
The probe surface 46 is generally configured to compatibly insert within a proximal opening 26 in the proximal end 22 of the catheter adapter 14. Following insertion of the probe 46 into the proximal end 22 of the catheter adapter 14, the conduit coupler 42 is rotated to interlock the coupler 42 and the flange 28 (via the sets of threads 30 and 44). During the process of interlocking the coupler 42 and the flange 28, the probe 46 is advanced into the lumen 16 of the catheter adapter 14 to an inserted position (as shown in
Reference will now be made to
In some embodiments, the catheter adapter 14 includes a valve 70 that can serve the dual function of a selectively sealing both the port 50 and the internal lumen 60 of the catheter adapter 14. The valve 70 can divide the lumen 60 into a distal lumen chamber 62 and a proximal lumen chamber 64. In some embodiments, the valve 70 includes a one-way valve portion 76, such as the duckbill portion shown. In some embodiments, this one-way valve portion 76 allows flow in the distal direction, but resist flow, such as up to or more than a standard venous pressure (e.g., about 500 Pa to about 1500 Pa), the proximal direction. By resisting flow in the proximal direction, the valve 70 can prevent blood leakage out the proximal opening 26 of the catheter adapter 14. Moreover, the one-way valve portion 76 can have a minimal crack pressure in the distal direction, to allow fluid flow when fluid begins to be introduced into the proximal end 22 of the catheter adapter 14.
As shown in
The one-way valve portion 76 can provide one-way valve functionality by limiting fluid flow in a single direction, such as the distal direction. As mentioned, the one-way valve portion 76 can be a duckbill valve, which can include two inwardly oriented flaps 80, 82, which are biased together toward a central position, forming a slit 84. The flaps 80, 82 can extend from the tube portion 78 inwardly and distally. Thus configured, the two inwardly oriented flaps 80, 82 can push together to close the valve in response to a fluid flow in a proximal direction (toward the distal end of the catheter adapter 14). Additionally, the two inwardly oriented flaps 80, 82 can be pushed apart to open a gap between these flaps 80, 82 in response to a fluid flow in a distal direction. As shown, the one-way valve portion 76 can be a duckbill style valve, while in other embodiments the one-way valve portion 76 can be any other pressure-activated valve that allows easy flow in the distal direction, but withstands venous pressure in the proximal direction (toward the proximal end of the catheter adapter 14).
In some embodiments, one-way valve portion 76 of the valve 70 is configured to open under the pressure of a fluid infusion through the proximal lumen opening 26 of the catheter adapter 14. As such, the one-way valve portion 76 can automatically open during fluid infusion and automatically close when the infusion stops. This ability can eliminate the need for a valve actuator that mechanically opens the valve.
In some embodiments, one or more slits 84 within the valve 70 permit passage of an introducer needle (not shown) through valve 70, thereby enabling a sharpened tip of the needle to extend distally beyond the tip portion 20 of the catheter 12. Following the catheterization procedure, the needle is removed from the catheter assembly 10 and is safely disposed.
In some embodiments, the needle is coated with a significant amount of silicone or similar fluid, such as fluorosilicone. The purpose of the coating fluid is threefold. Firstly, the coating fluid acts as a lubricant between the outer surface of the needle and the interfacing surfaces of slit 84. Thus, upon withdrawal of the needle from the valve 70, the coating fluid prevents undesirable adhesion between the outer surface of the needle and the interfacing surfaces of slit 84. Secondly, excess coating fluid accumulates within slit 84 thereby assisting in sealing the valve 70 to prevent blood from flowing back through the septum following removal of the needle. Excess coating fluid accumulates within slit 84 as needle is removed from catheter assembly 10. In particular, when the needle is being withdrawn through valve 70, the interfacing surfaces of slit 84 act to wipe the coating fluid from the outer surface of the needle thereby displacing the coating fluid into slit 84. Thirdly, the coating fluid acts as a lubricant to prevent undesirable adhesion between opposing surfaces of slit 84.
The coating fluid may include any biocompatible lubricant. In some embodiments, the coating fluid comprises a lubricant such as a non-wetting lubricant that is applied to an interface between the needle and the slit 84 to further eliminate possible leakage of fluid and/or air. A non-wetting lubricant may also be beneficial to prevent tearing or other damage to the slit that may occur when the needle is removed from the catheter assembly following catheterization. A non-wetting lubricant may also facilitate proper realignment of the opposing surfaces of slit 84 following removal of the needle. Non-limiting examples of a non-wetting lubricant include known Teflon based non-wetting materials such as Endura, from Endura Coating Co.; A20, E-20, 1000-S20, FEP Green, PTFE and X-40 from Tiodize; Cammie 2000 from AE Yale; 21845 from Ladd Research; MS122-22, MS122DF, MS-143DF, MS-122V MS-122VM, MS143V, MS-136W, MS-145W, U0316A2, U0316B2, MS-123, MS-125, MS-322 and MS-324 from Miller-Stepheson; and 633T2 from Otto Bock can also be used. Various non-Teflon based non-wetting lubricant type materials include Dylyn, from ART; Nyebar, Diamonex, NiLAD, TIDLN, Kiss-Cote, Titanium oxide; Fluocad Fluorochemical Coating FC-722, from 3M; Permacote from Dupont; Plasma Tech 1633 from Plasma Tech, Inc.; and silicone sprays.
Referring still to
Valve 70 can be designed to at least partially collapse inwardly when a predetermined pressure is applied to the valve 70 from the opening 52 of the port 50. The predetermined pressure can be generally less than the amount of force pressing against valve 70 through the opening 54 during an infusion of fluid via the port 50. In various embodiments, the tube portion of the valve 70 is flexible or semi-flexible. The valve 70 can be made of various flexible or semi-flexible materials including, for example, silicone, silicone rubber, polypropylene, or other suitable materials. The flexibility or rigidity of the material can affect predetermined pressure required to open the valve 70 and allow fluid into the catheter adapter 14. A more flexible material may require a smaller predetermined pressure, while a more rigid material may require a greater predetermined pressure.
As shown, the tubular shape of the tube portion 78 of the valve 70 provides a channel within the body of the valve 70 can collapse under the predetermined pressure. The tubular shape can also provide structural strength that maintains the outer surface 62 of the valve 70 against the opening 52 of the port until the predetermined pressure is applied. The thickness of the walls of the tubular-shaped valve 70 can be selected to adjust the predetermined pressure required to open the valve 70. Thus, by increasing the thickness of the walls of the tube portion 78, a greater pressure is required to open the valve 70. By decreasing the wall thickness, a lesser pressure required. Additionally, the wall thicknesses can be adjusted based on the flexibility for rigidity the material forming the valve 70. For instance, a more rigid material may permit thinner walls that enable the same threshold force to open the port valve as a thicker wall made of a more flexible material. Accordingly, the flexibility of the valve 70 combined with the shape and size of the valve 70 can permit the valve 70 to collapse when a predetermined pressure is applied to the valve 70 via the opening 54.
In various embodiments, the valve 70 is seated within a groove or channel 90, which comprises a recessed portion of the inner surface of the catheter adapter 14. The outer diameter of the valve 70 can be generally configured to compatibly and securely seat within the groove or channel 90. For example, in some embodiments, the outer diameter of the valve 70 is selected to be both smaller than or approximately equal to the diameter of the groove or channel 90 and slightly larger than the diameter of the inner lumen 60. As such, the valve 70 can be retained within the groove or channel 90 during use of the catheter assembly 10. In other configurations, other features, such as protrusions on the proximal and distal ends of the valve 70 assist to retain the valve 70 in place.
As shown in
As shown in
As shown in
As shown in
As shown, the valve 70 and/or the catheter adapter 14 can be configured to force fluid 110 to the proximal side of the valve 70 rather than to the distal side of the valve 70 or to both sides simultaneously. Accordingly, the distal end of the valve 70 can form a seal with the inner surface of the catheter adapter 14. For example, the outer portions of the distal side of the valve 70 can be adhered to the inner surface of the catheter adapter 14 to form a seal about the distal end of the valve 70. In another example, the outer portions of the distal side of the valve 70 can have a larger outer diameter or other outer dimensions than the portions of the valve 70 proximal to that end. Similarly, the inner dimensions of the catheter adapter 14 about the distal side of the valve 70 can have a smaller inner diameter than the portions of the catheter adapter 14 proximal this area. These examples can form a tighter seal between the distal end of the valve 70 and the catheter adapter 14 that encourages fluid to flow into the proximal lumen chamber 64. In yet another example, the outer portions of the proximal side of the valve 70 can have a smaller outer diameter or other outer dimensions than the portions of the valve 70 distal to that end. Similarly, the inner dimensions of the catheter adapter 14 about the proximal side of the valve 70 can have a larger inner diameter than the portions of the catheter adapter 14 distal this area. These examples can form a weaker seal between the proximal end of the valve 70 and the catheter adapter 14 that encourages fluid to flow into the proximal lumen chamber 64.
As shown in
As shown in
As shown in
The present catheter assembly 10 can provide a number of benefits. For example, present catheter assembly can be flushed through the side/top port 50. Since flushing can originate from the side port, and a cap 100 can be maintained on the proximal end of the catheter adapter 14 until the first IV set connection is made, which fully opens the valve for infusion. Thus, the catheter assembly can remain closed and sterile for a longer period. Present catheter assembly 10 can also reduce the number of components and assembly steps required.
The present invention may be embodied in other specific forms without departing from its structures, methods, or other essential characteristics as broadly described herein and claimed hereinafter. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application claims the benefit of U.S. Provisional Application No. 61/544,168 filed Oct. 6, 2011, entitled AN INTRAVENOUS CATHETER WITH DUCKBILL VALVE, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4387879 | Tauschinski | Jun 1983 | A |
4449693 | Gereg | May 1984 | A |
4758225 | Cox et al. | Jul 1988 | A |
4773552 | Boege et al. | Sep 1988 | A |
4781702 | Herrli | Nov 1988 | A |
4809679 | Shimonaka et al. | Mar 1989 | A |
4842591 | Luther | Jun 1989 | A |
4874377 | Newgard et al. | Oct 1989 | A |
4917668 | Haindl | Apr 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4950257 | Hibbs et al. | Aug 1990 | A |
5041097 | Johnson | Aug 1991 | A |
5053014 | Van Heugten | Oct 1991 | A |
5062836 | Wendell | Nov 1991 | A |
5064416 | Newgard et al. | Nov 1991 | A |
5084023 | Lemieux | Jan 1992 | A |
5085645 | Purdy et al. | Feb 1992 | A |
5098405 | Peterson et al. | Mar 1992 | A |
5108374 | Lemieux | Apr 1992 | A |
5127905 | Lemieux | Jul 1992 | A |
5154703 | Bonaldo | Oct 1992 | A |
5156596 | Balbierz et al. | Oct 1992 | A |
5176652 | Littrell | Jan 1993 | A |
5234410 | Graham et al. | Aug 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5290246 | Yamamoto et al. | Mar 1994 | A |
5295969 | Fischell et al. | Mar 1994 | A |
5330435 | Vaillancourt | Jul 1994 | A |
5350363 | Goode et al. | Sep 1994 | A |
5352205 | Dales et al. | Oct 1994 | A |
5405323 | Rogers et al. | Apr 1995 | A |
5456675 | Wolbring et al. | Oct 1995 | A |
5474544 | Lynn | Dec 1995 | A |
5487728 | Vaillancourt | Jan 1996 | A |
5520666 | Choudhury et al. | May 1996 | A |
5549566 | Elias et al. | Aug 1996 | A |
5549577 | Siegel et al. | Aug 1996 | A |
5575769 | Vaillancourt | Nov 1996 | A |
5613663 | Schmidt et al. | Mar 1997 | A |
5651772 | Arnett | Jul 1997 | A |
5657963 | Hinchliffe et al. | Aug 1997 | A |
5697915 | Lynn | Dec 1997 | A |
5730418 | Feith et al. | Mar 1998 | A |
5738144 | Rogers | Apr 1998 | A |
5749861 | Guala et al. | May 1998 | A |
5776096 | Fields | Jul 1998 | A |
5806831 | Paradis | Sep 1998 | A |
5817069 | Arnett | Oct 1998 | A |
5833674 | Turnbull et al. | Nov 1998 | A |
5911710 | Barry et al. | Jun 1999 | A |
5954698 | Pike | Sep 1999 | A |
5967490 | Pike | Oct 1999 | A |
6039302 | Cote, Sr. et al. | Mar 2000 | A |
6077244 | Botich et al. | Jun 2000 | A |
6117108 | Woehr et al. | Sep 2000 | A |
6171287 | Lynn et al. | Jan 2001 | B1 |
6273869 | Vaillancourt | Aug 2001 | B1 |
6287280 | Lampropoulos et al. | Sep 2001 | B1 |
6485473 | Lynn | Nov 2002 | B1 |
6575960 | Becker et al. | Jun 2003 | B2 |
6595981 | Huet | Jul 2003 | B2 |
6699221 | Vaillancourt | Mar 2004 | B2 |
6719726 | Meng et al. | Apr 2004 | B2 |
6740063 | Lynn | May 2004 | B2 |
6883778 | Newton et al. | Apr 2005 | B1 |
7008404 | Nakajima | Mar 2006 | B2 |
7347839 | Hiejima | Mar 2008 | B2 |
7396346 | Nakajima | Jul 2008 | B2 |
7470254 | Basta et al. | Dec 2008 | B2 |
7736339 | Woehr et al. | Jun 2010 | B2 |
7914494 | Hiejima | Mar 2011 | B2 |
20060163515 | Ruschke | Jul 2006 | A1 |
20070083157 | Belley et al. | Apr 2007 | A1 |
20070083162 | O'Reagan et al. | Apr 2007 | A1 |
20070233007 | Adams | Oct 2007 | A1 |
20080039796 | Nakajima | Feb 2008 | A1 |
20080108944 | Woehr et al. | May 2008 | A1 |
20080287921 | Bennett | Nov 2008 | A1 |
20090287154 | Harding et al. | Nov 2009 | A1 |
20100204648 | Stout et al. | Aug 2010 | A1 |
20100204675 | Woehr et al. | Aug 2010 | A1 |
20100222746 | Burkholz | Sep 2010 | A1 |
20110046570 | Stout et al. | Feb 2011 | A1 |
20110160662 | Stout et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
2 133 053 | Mar 1995 | CA |
20 2009 009 602 | Dec 2009 | DE |
0 369 314 | May 1990 | EP |
0 440 426 | Aug 1991 | EP |
0 968 736 | Jan 2000 | EP |
1 129 740 | Sep 2001 | EP |
1 679 043 | Jul 2006 | EP |
9311696 | Jun 1993 | WO |
9641649 | Dec 1996 | WO |
9800195 | Jan 1998 | WO |
9934849 | Jul 1999 | WO |
9938562 | Aug 1999 | WO |
2006037638 | Apr 2006 | WO |
2006059540 | Jun 2006 | WO |
2007044878 | Apr 2007 | WO |
2008014436 | Jan 2008 | WO |
2008052790 | May 2008 | WO |
2009114833 | Sep 2009 | WO |
2010093791 | Aug 2010 | WO |
2012002015 | Jan 2012 | WO |
Entry |
---|
Elson Silva, PhD, “Respecting Hydrology Science in the Patenting System,” pp. 1-7, Jan. 13, 2011. |
Number | Date | Country | |
---|---|---|---|
20130090607 A1 | Apr 2013 | US |
Number | Date | Country | |
---|---|---|---|
61544168 | Oct 2011 | US |